RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
171 hedge funds and large institutions have $248M invested in Revance Therapeutics, Inc. in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 49 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $429M → $248M (-$181M)
46% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 59
Holders
171
Holding in Top 10
3
Calls
$15M
Puts
$17.3M
Top Buyers
| 1 | +$18M | |
| 2 | +$13.3M | |
| 3 | +$5.93M | |
| 4 |
NM
Newtyn Management
New York
|
+$5.5M |
| 5 |
Millennium Management
New York
|
+$4.27M |
Top Sellers
| 1 | -$13M | |
| 2 | -$11M | |
| 3 | -$8.65M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$8.37M |
| 5 |
MAP
Madison Avenue Partners
New York
|
-$7.02M |